PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,547,000 | +115.6% | 240,454 | -4.9% | 0.00% | – |
| Q3 2020 | $2,573,000 | -29.5% | 252,770 | +3.1% | 0.00% | – |
| Q2 2020 | $3,652,000 | +43.0% | 245,109 | +17.0% | 0.00% | – |
| Q1 2020 | $2,554,000 | +53.9% | 209,515 | +99.8% | 0.00% | – |
| Q4 2019 | $1,660,000 | +117.6% | 104,886 | +68.8% | 0.00% | – |
| Q3 2019 | $763,000 | – | 62,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 13,822,463 | $318,884,000 | 2.79% |
| HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
| HARVEST MANAGEMENT LLC | 70,000 | $1,615,000 | 1.32% |
| EQUITEC PROPRIETARY MARKETS, LLC | 215,300 | $4,967,000 | 1.30% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 206,867 | $4,773,000 | 1.00% |
| Boxer Capital, LLC | 1,123,105 | $25,910,000 | 0.83% |
| TIG Advisors, LLC | 709,282 | $16,363,000 | 0.82% |
| Newtyn Management, LLC | 153,617 | $3,544,000 | 0.82% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 857,705 | $19,787,000 | 0.81% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 205,800 | $4,748,000 | 0.74% |